Nuveen’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Nuveen’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-83,542	Closed	-$1.5M	–	1183
2017 Q4	$1.5M	Buy	83,542 +163	+0.2%	+$2.01K	0.01%	652
2017 Q3	$984K	Buy	83,379 +27,883	+50%	+$313K	0.01%	768
2017 Q2	$583K	Buy	55,496 +30,237	+120%	+$308K	﹤0.01%	900
2017 Q1	$278K	Sell	25,259 -8,397	-25%	-$97.5K	﹤0.01%	1276
2016 Q4	$456K	Sell	33,656 -7,851	-19%	-$110K	﹤0.01%	1331
2016 Q3	$511K	Buy	+41,507	New	+$489K	﹤0.01%	1237

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Nuveen's SCMP Position: Q1 2018 in Review

Nuveen sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 83,542 shares — an estimated $1.5M sold.

Nuveen first reported a position in SCMP in Q3 2016 and held it in 6 quarters. The position peaked at $1.5M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Nuveen reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Nuveen sold 83,542 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.5M.
Nuveen first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2016 and held it in 6 quarters.
Nuveen's Sucampo Pharmaceuticals, Inc. position peaked at $1.5M in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Nuveen's 13F filing for Q1 2018, filed 14 May 2018.